Syra Health Corp.
SYRA
$0.10
-$0.0069-6.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.86M | 2.01M | 2.25M | 1.97M | 1.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.86M | 2.01M | 2.25M | 1.97M | 1.75M |
| Cost of Revenue | 1.27M | 1.55M | 1.59M | 1.62M | 1.45M |
| Gross Profit | 589.20K | 455.40K | 668.30K | 350.00K | 299.80K |
| SG&A Expenses | 1.02M | 954.90K | 1.04M | 1.45M | 1.45M |
| Depreciation & Amortization | 6.80K | 7.30K | 25.50K | 17.40K | 12.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.33M | 2.51M | 2.68M | 3.36M | 3.20M |
| Operating Income | -473.30K | -501.70K | -428.90K | -1.39M | -1.44M |
| Income Before Tax | -472.30K | -504.40K | -417.50K | -1.39M | -1.45M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -472.30K | -504.40K | -417.50K | -1.39M | -1.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -472.30K | -504.40K | -417.50K | -1.39M | -1.45M |
| EBIT | -473.30K | -501.70K | -428.90K | -1.39M | -1.44M |
| EBITDA | -466.50K | -494.40K | -403.40K | -1.37M | -1.43M |
| EPS Basic | -0.04 | -0.05 | -0.06 | -0.21 | -0.22 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.13 | -0.14 |
| EPS Diluted | -0.04 | -0.05 | -0.06 | -0.21 | -0.22 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.13 | -0.14 |
| Average Basic Shares Outstanding | 11.59M | 9.84M | 7.26M | 6.60M | 6.50M |
| Average Diluted Shares Outstanding | 11.59M | 9.84M | 7.26M | 6.60M | 6.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |